Post Tagged with: "NASDAQ:NVAX"

Watch List : SLM Corporation (NASDAQ:SLM), Novavax(NASDAQ:NVAX), Herman Miller Inc. (NASDAQ:MLHR), First Interstate Bancsystem Inc. (NASDAQ:FIBK), JPMorgan Chase & Co. (NYSE:JPM)

October 27, 2014 at 2:05 pm 0 comments

SLM Corp (NYSE:SLM) last issued its quarterly earnings data on Wednesday, October 22nd. The company reported $0.17 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.28) by $0.45. During the same quarter in the prior year, theRead More

Stock Highlights: Novavax(NASDAQ:NVAX), Transocean (NYSE:RIG), Microsemi Corporation (NASDAQ:MSCC), Barracuda Networks(NYSE:CUDA), Sungy Mobile Limited (NASDAQ:GOMO)

October 25, 2014 at 4:49 pm 0 comments

Novavax Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company focused on the discovery development and commercialization of recombinant nanoparticle vaccines and adjuvants announced that Gregory Glenn M.D. Senior Vice President Research and Development at Novavax will present new immunogenicity data from Novavax’Read More

Momentum Stocks : SGOCO Group, (NASDAQ:SGOC), Criteo SA (NASDAQ:CRTO), Western Refining Logistics, LP (NYSE:WNRL), Intuit Inc. (NASDAQ:INTU), Novavax(NASDAQ:NVAX)

September 9, 2014 at 11:44 am 0 comments

On August 28, SGOCO Group, Ltd. (NASDAQ:SGOC), a company focused on product design, distribution and brand development in the China display market, announced a new on-line sales platform on to accelerate the delivery of high quality service and products.Read More

Biotech Most Active: Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD), Novavax (NASDAQ:NVAX), Gilead Sciences (NASDAQ:GILD)

March 5, 2014 at 12:48 pm 0 comments

Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) dropped 3.8% after posting fourth quarter loss per share of $0.11, missing the Zacks Consensus Estimate of earnings per share of $0.15. Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $7.09 in last tradingRead More

Healthcare Top Gainers: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Cell Therapeutics Inc (NASDAQ:CTIC), Novavax (NASDAQ:NVAX)

February 28, 2014 at 1:04 pm 0 comments

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock was upgrade from Hold to Buy at Maxim Group on26-Feb-14. Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) closed at $8.99 in last trading session. Yesterday share price of the company was traded in the range ofRead More